Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness

Slide: 27 of 35

Results of Comparative Effectiveness Studies of Antipsychotics as Treatment for Bipolar Disorder

No statistically significant difference in assessment of mania, depression, or global impressions of bipolar disorder is noted in comparisons of haloperidol and aripiprazole. The strength of evidence for this finding is low.

No statistically significant difference in total score for mania assessment is found in comparisons of haloperidol with olanzapine or risperidone. The strength of evidence for this finding is low.

In bipolar disorder, haloperidol produces lower relapse rates than aripiprazole and provides better response rates than ziprasidone. The strength of evidence for this finding was not rated.